226 related articles for article (PubMed ID: 9298538)
21. Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.
Kursar JD; Nelson DL; Wainscott DB; Cohen ML; Baez M
Mol Pharmacol; 1992 Oct; 42(4):549-57. PubMed ID: 1331748
[TBL] [Abstract][Full Text] [Related]
22. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization.
Cohen Z; Bouchelet I; Olivier A; Villemure JG; Ball R; Stanimirovic DB; Hamel E
J Cereb Blood Flow Metab; 1999 Aug; 19(8):908-17. PubMed ID: 10458598
[TBL] [Abstract][Full Text] [Related]
23. The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor.
Cerutis DR; Hass NA; Iversen LJ; Bylund DB
Mol Pharmacol; 1994 Jan; 45(1):20-8. PubMed ID: 8302276
[TBL] [Abstract][Full Text] [Related]
24. Expression and pharmacological characterization of a canine 5-hydroxytryptamine1D receptor subtype.
Zgombick JM; Weinshank RL; Macchi M; Schechter LE; Branchek TA; Hartig PR
Mol Pharmacol; 1991 Dec; 40(6):1036-42. PubMed ID: 1758439
[TBL] [Abstract][Full Text] [Related]
25. Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes.
Shimizu M; Nishida A; Zensho H; Yamawaki S
J Pharmacol Exp Ther; 1996 Dec; 279(3):1551-8. PubMed ID: 8968382
[TBL] [Abstract][Full Text] [Related]
26. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells.
Mahé C; Loetscher E; Dev KK; Bobirnac I; Otten U; Schoeffter P
Neuropharmacology; 2005 Jul; 49(1):40-7. PubMed ID: 15992579
[TBL] [Abstract][Full Text] [Related]
27. Novel interaction between the human 5-HT7 receptor isoforms and PLAC-24/eIF3k.
De Martelaere K; Lintermans B; Haegeman G; Vanhoenacker P
Cell Signal; 2007 Feb; 19(2):278-88. PubMed ID: 16935469
[TBL] [Abstract][Full Text] [Related]
28. Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor.
Brüss M; Bönisch H; Bühlen M; Nöthen MM; Propping P; Göthert M
Pharmacogenetics; 1999 Feb; 9(1):95-102. PubMed ID: 10208648
[TBL] [Abstract][Full Text] [Related]
29. Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines.
Mahé C; Bernhard M; Bobirnac I; Keser C; Loetscher E; Feuerbach D; Dev KK; Schoeffter P
Br J Pharmacol; 2004 Oct; 143(3):404-10. PubMed ID: 15339860
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning and functional characterization of a rat somatostatin sst2(b) receptor splice variant.
Schindler M; Kidd EJ; Carruthers AM; Wyatt MA; Jarvie EM; Sellers LA; Feniuk W; Humphrey PP
Br J Pharmacol; 1998 Sep; 125(1):209-17. PubMed ID: 9776362
[TBL] [Abstract][Full Text] [Related]
31. Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulation.
Sharif NA; Drace CD; Williams GW; Crider JY
J Pharm Pharmacol; 2004 Oct; 56(10):1267-74. PubMed ID: 15482641
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
33. A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization.
Chapin EM; Andrade R
J Pharmacol Exp Ther; 2001 Apr; 297(1):395-402. PubMed ID: 11259568
[TBL] [Abstract][Full Text] [Related]
34. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain.
Claeysen S; Sebben M; Becamel C; Bockaert J; Dumuis A
Mol Pharmacol; 1999 May; 55(5):910-20. PubMed ID: 10220570
[TBL] [Abstract][Full Text] [Related]
35. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
[TBL] [Abstract][Full Text] [Related]
36. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
[TBL] [Abstract][Full Text] [Related]
37. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
[TBL] [Abstract][Full Text] [Related]
38. Signalling properties and pharmacology of a 5-HT7 -type serotonin receptor from Tribolium castaneum.
Vleugels R; Lenaerts C; Vanden Broeck J; Verlinden H
Insect Mol Biol; 2014 Apr; 23(2):230-43. PubMed ID: 24330075
[TBL] [Abstract][Full Text] [Related]
39. Cloning and expression of ligand-gated ion-channel receptor L2 in central nervous system.
Houtani T; Munemoto Y; Kase M; Sakuma S; Tsutsumi T; Sugimoto T
Biochem Biophys Res Commun; 2005 Sep; 335(2):277-85. PubMed ID: 16083862
[TBL] [Abstract][Full Text] [Related]
40. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
